[1]
Bendelman, G. et al. 2024. What’s new in the treatment of amyloidosis? Part 2: Cardiomyopathy due to transthyretin amyloidosis. Revista del Hospital Italiano de Buenos Aires. 44, 1 (Mar. 2024), e0000353. DOI:https://doi.org/10.51987/revhospitalbaires.v44i1.353.